Clinical Trials Browser

Phase 2 × Advanced Non-small Cell Lung Cancer × atezolizumab × Clear all

NCT03014648 2023-12-13

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 2 Completed

28 enrolled 22 charts

Advanced Non-small Cell Lung Cancer